A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas
2017 · Journal of Neuro-Oncology · 33 citations
https://doi.org/10.1007/s11060-017-2469-x
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
1.0K
Citations
20
h-index
25
i10-index
Maryanne H. Marymont is an academic researcher from Northwestern University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Meningioma and schwannoma management & Brain Metastases and Treatment. The author has an h-index of 20, co-authored 49 publications.
https://doi.org/10.1007/s11060-017-2469-x
https://doi.org/10.6004/jnccn.2006.0050
Click to start Chat